$5 or 3c by November?

Extract from latest announcement

ResApp’s sleep apnoea program is one of three major clinical programs being undertaken by the company. Recruitment in ResApp’s two pivotal clinical studies targeting the acute diagnosis of respiratory disease using cough sounds recorded on a smartphone, SMARTCOUGH-C-2 (recruiting in the United States) and Breathe Easy (recruiting in Australia), is on track in both cases and should be completed by the end of this month. Results will be reported soon afterwards, following the finalisation of clinical adjudication and data verification

“Should” be completed....may be either side of next Tuesday, claiming a blood bath will take place is not inline with Ann.

Oh well, I bet there will be coz even if the results are in but no announcement of results this should be reported to the market....if not....if nothing clarifying at the end of this month = bloodbath. But I don't expect that will happen as this company has been very fair and consistent with their anns.